Sangamo Therapeutics
SGMO
#8058
Rank
NZ$0.38 B
Marketcap
$1.86
Share price
-4.46%
Change (1 day)
-7.48%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -NZ$0.22 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$52.29 Million. In 2023 the company made an earning of -NZ$0.21 Billion, an increase over its 2022 earnings that were of -NZ$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.22 Billion6.06%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.35 Billion9.79%
2021 -NZ$0.32 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$97.78 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$81.29 Million75.62%
2014 -NZ$46.29 Million0.13%
2013 -NZ$46.23 Million
2011 -NZ$62.15 Million43.66%
2010 -NZ$43.26 Million28.52%
2009 -NZ$33.66 Million-23.55%
2008 -NZ$44.03 Million2.45%
2007 -NZ$42.98 Million19.5%
2006 -NZ$35.97 Million50.78%
2005 -NZ$23.86 Million75%
2004 -NZ$13.63 Million-33.25%
2003 -NZ$20.42 Million-62.27%
2002 -NZ$54.12 Million102.82%
2001 -NZ$26.69 Million23.21%
2000 -NZ$21.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.30 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.41 Billion 75.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.11 B-3,586.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.30 B-1,520.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.77 B-1,292.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.25 B-13,094.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.67 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.97 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA